SCHEMBL6606561

SCHEMBL6606561

CCOC(=O)c1ccc(-c2ccc(OC)c3c2OCCO3)cc1COC(C)=O

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.46
LMNA P02545 3/20 0.46
KDM4E B2RXH2 2/20 0.46
HSD17B10 Q99714 1/20 0.46
MAPT P10636 5/20 0.39
TSHR P16473 2/20 0.39
MAPK1 P28482 2/20 0.39
MAPK10 P53779 1/20 0.39
HTT P42858 2/20 0.38
L3MBTL1 Q9Y468 3/20 0.37
MEN1 O00255 3/20 0.37
KMT2A Q03164 3/20 0.37
PRKCZ Q05513 2/20 0.36
PRKCI P41743 1/20 0.36
CRHBP P24387 1/20 0.35
CRHR2 Q13324 1/20 0.35
MYC P01106 1/20 0.35
NPC1 O15118 2/20 0.35
ALPL P05186 1/20 0.35
RAB9A P51151 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6604621 0.86 LMNA (0.50) ALDH1A1LMNAKDM4EHSD17B10MAPT
SCHEMBL6837558 0.78 MAPT (0.48) ALDH1A1LMNAKDM4EHSD17B10MAPT
SCHEMBL17613967 0.75 ALDH1A1 (0.52) ALDH1A1LMNAKDM4EHSD17B10MAPT
SCHEMBL6602481 0.73 KDM4E (0.56) ALDH1A1LMNAKDM4EHSD17B10MAPT
SCHEMBL12565687 0.71 MAPT (0.42) ALDH1A1LMNAKDM4EHSD17B10MAPT
SCHEMBL6607849 0.68 CA12 (0.49) ALDH1A1LMNAHSD17B10MAPTTSHR
SCHEMBL8312017 0.67 LMNA (0.47) ALDH1A1LMNAKDM4EHSD17B10MAPT
SCHEMBL6836428 0.67 LMNA (0.52) ALDH1A1LMNAKDM4EHSD17B10TSHR
SCHEMBL29900125 0.67 ERN1 (0.52) ALDH1A1LMNAMAPTTSHRMAPK10
SCHEMBL12565873 0.66 RAB9A (0.42) ALDH1A1LMNAKDM4EHSD17B10MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1110961-B1 OXYGENIC HETEROCYCLIC COMPOUNDS KYOWA HAKKO KOGYO KK (JP) 2004-07-14 EP disclosed
US-6376535-B2 PHOSPHODIESTERASE (PDE) INHIBITOR KYOWA HAKKO KOGYO CO., LTD. (JP) 2002-04-23 US disclosed
US-20010056117-A1 Oxygen-containing heterocyclic compounds KYOWA HAKKO KIRIN CO., LTD. (JP) 2001-12-27 US disclosed
EP-1110961-A1 OXYGENIC HETEROCYCLIC COMPOUNDS KYOWA HAKKO KOGYO CO., LTD. (JP) 2001-06-27 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20010056117-A1 Oxygen-containing heterocyclic compounds CBR1, CBR3, MT-CO1 ALDH1A1 232/4885LMNA 4242/4885KDM4E 444/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.